Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neurofibromatosis 1 × Lamotrigine × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Noonan Syndrome 1 Neurofibromatosis 1 1 Cognition Disorders 1

Interventions

AZD 6244 9 trametinib 3 Lovastatin 3 mirdametinib 2 Sirolimus 2 Inhalation 2 Everolimus 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 pirfenidone 1 peginterferon alfa-2b 1 omipalisib 1 fludarabine 1 cediranib 1 binimetinib 1 Vitamin D 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Sunitinib 1 Saline Solution 1 Rituximab 1 Radiotherapy 1 Photochemotherapy 1 Methotrexate 1 Melphalan 1 Levetiracetam 1 Lenalidomide 1 Lamotrigine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03504501 2023-11-30

SynCoRAS

Technical University of Munich

Phase 2 Terminated

Cognition Disorders, Neurofibromatosis 1, Noonan Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡